Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-10-10
2011-10-25
Tsang, Cecilia J (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
08044028
ABSTRACT:
The present invention relates to the cosmetic use of oligopeptides, cosmetic preparations which comprise such oligopeptides as well as certain oligopeptide derivatives themselves.
REFERENCES:
patent: 4966848 (1990-10-01), Smith et al.
patent: 5223421 (1993-06-01), Smith et al.
patent: 5837218 (1998-11-01), Peers et al.
patent: 6713605 (2004-03-01), Blecha et al.
patent: 2005/0142092 (2005-06-01), Lintner
patent: 197 56 377 (1999-06-01), None
patent: 74 39242 (1974-11-01), None
patent: WO 00/43417 (2000-07-01), None
patent: WO 00/57895 (2000-10-01), None
patent: WO 01/30368 (2001-05-01), None
patent: WO 01/47540 (2001-07-01), None
patent: WO 03/037933 (2003-05-01), None
patent: WO 03/042387 (2003-05-01), None
patent: WO 03/068141 (2003-08-01), None
patent: WO 2004/033668 (2004-04-01), None
patent: WO 2006/042661 (2006-04-01), None
Gaczynska, M., et al, “Proline- and arginine-rich peptides constitute a novel class of allosteric inhibitors of proteasome activity,” Biochemistry (2003), 42(29), 8663-8670.
Chan R.Y. and Gallo R.L.: “PR-39, a Syndecan-inducing Antimicrobial eptide, Binds and Affects p130Cas” J. Biol Chem, vol. 273, No. 44, Oct. 30, 1998, pp. 28978-28985, XP-002322010.
Gallo R.L. et al: “Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds.” Proceedings of the National Academy of Sciences of the United States of America. Nov. 8, 1994, vol. 91, No. 23, Nov. 8, 1994, pp. 11035-11039, XP001022264 ISSN: 0027-8424.
Gaczynska Maria et al: “Proline- and Arginine-Rich Peptides Constitute a Novel Class of Allosteric Inhibitors of Proteasome Activity” Biochemistry, American Chemical Society, Easton, PA, US, vol. 42, No. 29, Jul. 29, 2003, pp. 8663-8670, XP002276092 ISSN: 0006-2960.
Chan Y R, Zanetti M, Gennaro R, Gallo RL: “Anti-Microbial Activity and Cell Binding are Controled by Sequence Determinants in the Anti-Microbial Peptide PR-39” J. Invest.Dermat., vol. 116, No. 2, Feb. 2, 2001, pp. 230-235, XP009045423.
Zaiou M and Gallo RL: “Cathelicidins, essential gene-encoded mammalian antibiotics” J Mol Med, vol. 80, 2002, pp. 549-561, XP009045301.
Gudmundsson G, Magnusson K.P., Chowdhary B.P., Johansson M., Andersson L., Boman H.G.: “Structure of the gene for porcine peptide antiobiotic PR-39, a cathelin gene family member: Comparative mapping of the locus for the human peptide anti biotic FALL-39” Proc. Natl.Acad.Sci USA, vol. 92, Jul. 1995, pp. 7085-7089.
Gallo, R.L. & Huttner K.M., J. Invest. Dermatol. 1998, 111, 739-43 “Antimicrobial Peptides: An Emerging Concept in Cutaneous Biology”.
R. Lockhhead et al., “Encyclopedia of Polymers and Thickeners for Cosmetics”, Cosmetics & Toiletries, vol. 108, (May 1993), pp. 95-114, 116-124, 127-130, 132-135.
“Kosmetische Färbemittel”, Farbstoffkommission der Deutschen Forschungsgemeinschaft, Verlag Chemie, Weinheim, (1984), pp. 81-106.
Contet-Audonneau Jean-Luc
Danoux Louis
Moussou Philippe
Pauly Gilles
Cognis France S.A.S.
Fox Rothschild LLP
Heard Thomas
Tsang Cecilia J
LandOfFree
Oligopeptides and their use in cosmetics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligopeptides and their use in cosmetics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligopeptides and their use in cosmetics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4256563